{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:04:27Z","timestamp":1792724667224,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"7471","license":[{"start":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T00:00:00Z","timestamp":1381276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T00:00:00Z","timestamp":1381276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2013,10,17]]},"DOI":"10.1038\/nature12647","type":"journal-article","created":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T11:56:08Z","timestamp":1381233368000},"page":"327-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":519,"title":["A regenerative approach to the treatment of multiple sclerosis"],"prefix":"10.1038","volume":"502","author":[{"given":"Vishal A.","family":"Deshmukh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Tardif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costas A.","family":"Lyssiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea C.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Kerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnan","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan G.","family":"Swoboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insha","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred H.","family":"Gage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyrios N.","family":"Theofilopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke L.","family":"Lairson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,9]]},"reference":[{"key":"BFnature12647_CR1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrn2480","volume":"9","author":"RJ Franklin","year":"2008","unstructured":"Franklin, R. J. & Ffrench-Constant, C. Remyelination in the CNS: from biology to therapy. Nature Rev. Neurosci. 9, 839\u2013855 (2008)","journal-title":"Nature Rev. Neurosci."},{"key":"BFnature12647_CR2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn917","volume":"3","author":"RJ Franklin","year":"2002","unstructured":"Franklin, R. J. Why does remyelination fail in multiple sclerosis? Nature Rev. Neurosci. 3, 705\u2013714 (2002)","journal-title":"Nature Rev. Neurosci."},{"key":"BFnature12647_CR3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nm837","volume":"9","author":"MC Nunes","year":"2003","unstructured":"Nunes, M. C. et al. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nature Med. 9, 439\u2013447 (2003)","journal-title":"Nature Med."},{"key":"BFnature12647_CR4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1083\/jcb.200210110","volume":"161","author":"S Belachew","year":"2003","unstructured":"Belachew, S. et al. Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. J. Cell Biol. 161, 169\u2013186 (2003)","journal-title":"J. Cell Biol."},{"key":"BFnature12647_CR5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nn.2702","volume":"14","author":"JK Huang","year":"2011","unstructured":"Huang, J. K. et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nature Neurosci. 14, 45\u201353 (2011)","journal-title":"Nature Neurosci."},{"key":"BFnature12647_CR6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0896-6273(00)80359-1","volume":"19","author":"JM Gensert","year":"1997","unstructured":"Gensert, J. M. & Goldman, J. E. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 19, 197\u2013203 (1997)","journal-title":"Neuron"},{"key":"BFnature12647_CR7","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1523\/JNEUROSCI.20-06-02218.2000","volume":"20","author":"PJ Horner","year":"2000","unstructured":"Horner, P. J. et al. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J. Neurosci. 20, 2218\u20132228 (2000)","journal-title":"J. Neurosci."},{"key":"BFnature12647_CR8","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ana.22415","volume":"69","author":"D Kremer","year":"2011","unstructured":"Kremer, D., Aktas, O., Hartung, H. P. & Kury, P. The complex world of oligodendroglial differentiation inhibitors. Ann. Neurol. 69, 602\u2013618 (2011)","journal-title":"Ann. Neurol."},{"key":"BFnature12647_CR9","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1016\/j.febslet.2011.04.037","volume":"585","author":"JR Patel","year":"2011","unstructured":"Patel, J. R. & Klein, R. S. Mediators of oligodendrocyte differentiation during remyelination. FEBS Lett. 585, 3730\u20133737 (2011)","journal-title":"FEBS Lett."},{"key":"BFnature12647_CR10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJMoa010994","volume":"346","author":"A Chang","year":"2002","unstructured":"Chang, A., Tourtellotte, W. W., Rudick, R. & Trapp, B. D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 346, 165\u2013173 (2002)","journal-title":"N. Engl. J. Med."},{"key":"BFnature12647_CR11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jnr.10700","volume":"73","author":"DM Chari","year":"2003","unstructured":"Chari, D. M., Huang, W. L. & Blakemore, W. F. Dysfunctional oligodendrocyte progenitor cell (OPC) populations may inhibit repopulation of OPC depleted tissue. J. Neurosci. Res. 73, 787\u2013793 (2003)","journal-title":"J. Neurosci. Res."},{"key":"BFnature12647_CR12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1523\/JNEUROSCI.18-02-00601.1998","volume":"18","author":"G Wolswijk","year":"1998","unstructured":"Wolswijk, G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 18, 601\u2013609 (1998)","journal-title":"J. Neurosci."},{"key":"BFnature12647_CR13","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/brain\/awn096","volume":"131","author":"T Kuhlmann","year":"2008","unstructured":"Kuhlmann, T. et al. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131, 1749\u20131758 (2008)","journal-title":"Brain"},{"key":"BFnature12647_CR14","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1083\/jcb.109.6.3411","volume":"109","author":"IK Hart","year":"1989","unstructured":"Hart, I. K., Richardson, W. D., Bolsover, S. R. & Raff, M. C. PDGF and intracellular signaling in the timing of oligodendrocyte differentiation. J. Cell Biol. 109, 3411\u20133417 (1989)","journal-title":"J. Cell Biol."},{"key":"BFnature12647_CR15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/dbio.2001.0293","volume":"235","author":"N Billon","year":"2001","unstructured":"Billon, N., Tokumoto, Y., Forrest, D. & Raff, M. Role of thyroid hormone receptors in timing oligodendrocyte differentiation. Dev. Biol. 235, 110\u2013120 (2001)","journal-title":"Dev. Biol."},{"key":"BFnature12647_CR16","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1093\/emboj\/20.18.5261","volume":"20","author":"YM Tokumoto","year":"2001","unstructured":"Tokumoto, Y. M., Tang, D. G. & Raff, M. C. Two molecularly distinct intracellular pathways to oligodendrocyte differentiation: role of a p53 family protein. EMBO J. 20, 5261\u20135268 (2001)","journal-title":"EMBO J."},{"key":"BFnature12647_CR17","doi-asserted-by":"crossref","first-page":"16363","DOI":"10.1073\/pnas.0407262101","volume":"101","author":"M Fernandez","year":"2004","unstructured":"Fernandez, M. et al. Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc. Natl Acad. Sci. USA 101, 16363\u201316368 (2004)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature12647_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1677\/JME-09-0067","volume":"44","author":"L Calz\u00e0","year":"2010","unstructured":"Calz\u00e0, L., Fernandez, M. & Giardino, L. Cellular approaches to central nervous system remyelination stimulation: thyroid hormone to promote myelin repair via endogenous stem and precursor cells. J. Mol. Endocrinol. 44, 13\u201323 (2010)","journal-title":"J. Mol. Endocrinol."},{"key":"BFnature12647_CR19","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1242\/dev.120.5.1097","volume":"120","author":"BA Barres","year":"1994","unstructured":"Barres, B. A., Lazar, M. A. & Raff, M. C. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120, 1097\u20131108 (1994)","journal-title":"Development"},{"key":"BFnature12647_CR20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuropharm.2010.04.014","volume":"59","author":"CE Buckley","year":"2010","unstructured":"Buckley, C. E. et al. Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects. Neuropharmacology 59, 149\u2013159 (2010)","journal-title":"Neuropharmacology"},{"key":"BFnature12647_CR21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2003.09.002","volume":"71","author":"C Ibanez","year":"2003","unstructured":"Ibanez, C. et al. Steroids and the reversal of age-associated changes in myelination and remyelination. Prog. Neurobiol. 71, 49\u201356 (2003)","journal-title":"Prog. Neurobiol."},{"key":"BFnature12647_CR22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/brain\/awn334","volume":"132","author":"AS Baer","year":"2009","unstructured":"Baer, A. S. et al. Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain 132, 465\u2013481 (2009)","journal-title":"Brain"},{"key":"BFnature12647_CR23","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1002\/jnr.22434","volume":"88","author":"L Joubert","year":"2010","unstructured":"Joubert, L. et al. Chemical inducers and transcriptional markers of oligodendrocyte differentiation. J. Neurosci. Res. 88, 2546\u20132557 (2010)","journal-title":"J. Neurosci. Res."},{"key":"BFnature12647_CR24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0896-6273(90)90216-3","volume":"5","author":"AL Gard","year":"1990","unstructured":"Gard, A. L. & Pfeiffer, S. E. Two proliferative stages of the oligodendrocyte lineage (A2B5+O4\u2212and O4+GalC\u2212) under different mitogenic control. Neuron 5, 615\u2013625 (1990)","journal-title":"Neuron"},{"key":"BFnature12647_CR25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0962-8924(93)90213-K","volume":"3","author":"SE Pfeiffer","year":"1993","unstructured":"Pfeiffer, S. E., Warrington, A. E. & Bansal, R. The oligodendrocyte and its many cellular processes. Trends Cell Biol. 3, 191\u2013197 (1993)","journal-title":"Trends Cell Biol."},{"key":"BFnature12647_CR26","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/nprot.2009.157","volume":"4","author":"N Gaspard","year":"2009","unstructured":"Gaspard, N. et al. Generation of cortical neurons from mouse embryonic stem cells. Nature Protocols 4, 1454\u20131463 (2009)","journal-title":"Nature Protocols"},{"key":"BFnature12647_CR27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0092-8674(92)90531-G","volume":"70","author":"BA Barres","year":"1992","unstructured":"Barres, B. A. et al. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70, 31\u201346 (1992)","journal-title":"Cell"},{"key":"BFnature12647_CR28","first-page":"312","volume":"45","author":"AJ Eshleman","year":"1994","unstructured":"Eshleman, A. J., Henningsen, R. A., Neve, K. A. & Janowsky, A. Release of dopamine via the human transporter. Mol. Pharmacol. 45, 312\u2013316 (1994)","journal-title":"Mol. Pharmacol."},{"key":"BFnature12647_CR29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF00431939","volume":"77","author":"JW McKearney","year":"1982","unstructured":"McKearney, J. W. Stimulant actions of histamine H1 antagonists on operant behavior in the squirrel monkey. Psychopharmacol. 77, 156\u2013158 (1982)","journal-title":"Psychopharmacol."},{"key":"BFnature12647_CR30","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1021\/jm970525a","volume":"40","author":"GE Agoston","year":"1997","unstructured":"Agoston, G. E. et al. Novel N-substituted 3\u03b1-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter. J. Med. Chem. 40, 4329\u20134339 (1997)","journal-title":"J. Med. Chem."},{"key":"BFnature12647_CR31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/dneu.20976","volume":"72","author":"F De Angelis","year":"2012","unstructured":"De Angelis, F., Bernardo, A., Magnaghi, V., Minghetti, L. & Tata, A. M. Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation and differentiation. Dev. Neurobiol. 72, 713\u2013728 (2012)","journal-title":"Dev. Neurobiol."},{"key":"BFnature12647_CR32","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/brain\/awh217","volume":"127","author":"MF Stidworthy","year":"2004","unstructured":"Stidworthy, M. F. et al. Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Brain 127, 1928\u20131941 (2004)","journal-title":"Brain"},{"key":"BFnature12647_CR33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrneurol.2010.37","volume":"6","author":"C Taveggia","year":"2010","unstructured":"Taveggia, C., Feltri, M. L. & Wrabetz, L. Signals to promote myelin formation and repair. Nature Rev. Neurol. 6, 276\u2013287 (2010)","journal-title":"Nature Rev. Neurol."},{"key":"BFnature12647_CR34","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1046\/j.1471-4159.2001.00356.x","volume":"77","author":"F Ragheb","year":"2001","unstructured":"Ragheb, F. et al. Pharmacological and functional characterization of muscarinic receptor subtypes in developing oligodendrocytes. J. Neurochem. 77, 1396\u20131406 (2001)","journal-title":"J. Neurochem."},{"key":"BFnature12647_CR35","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1096\/fasebj.9.8.7768353","volume":"9","author":"CC Felder","year":"1995","unstructured":"Felder, C. C. Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J. 9, 619\u2013625 (1995)","journal-title":"FASEB J."},{"key":"BFnature12647_CR36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0733-8619(18)30061-6","volume":"13","author":"T Owens","year":"1995","unstructured":"Owens, T. & Sriram, S. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol. Clin. 13, 51\u201373 (1995)","journal-title":"Neurol. Clin."},{"key":"BFnature12647_CR37","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.4049\/jimmunol.178.8.5366","volume":"178","author":"BR Lawson","year":"2007","unstructured":"Lawson, B. R. et al. Inhibition of transmethylation down-regulates CD4 T cell activation and curtails development of autoimmunity in a model system. J. Immunol. 178, 5366\u20135374 (2007)","journal-title":"J. Immunol."},{"key":"BFnature12647_CR38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00415-008-6003-0","volume":"255","author":"E Mix","year":"2008","unstructured":"Mix, E., Meyer-Rienecker, H. & Zettl, U. K. Animal models of multiple sclerosis for the development and validation of novel therapies\u2014potential and limitations. J. Neurol. 255 (Suppl 6). 7\u201314 (2008)","journal-title":"J. Neurol."},{"key":"BFnature12647_CR39","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.it.2005.08.014","volume":"26","author":"L Steinman","year":"2005","unstructured":"Steinman, L. & Zamvil, S. S. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol. 26, 565\u2013571 (2005)","journal-title":"Trends Immunol."},{"key":"BFnature12647_CR40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jaut.2011.06.003","volume":"37","author":"R Aharoni","year":"2011","unstructured":"Aharoni, R. et al. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate. J. Autoimmun. 37, 228\u2013241 (2011)","journal-title":"J. Autoimmun."},{"key":"BFnature12647_CR41","doi-asserted-by":"crossref","first-page":"9074","DOI":"10.1523\/JNEUROSCI.1238-10.2010","volume":"30","author":"L Liu","year":"2010","unstructured":"Liu, L. et al. Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells. J. Neurosci. 30, 9074\u20139083 (2010)","journal-title":"J. Neurosci."},{"key":"BFnature12647_CR42","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nm1664","volume":"13","author":"S Mi","year":"2007","unstructured":"Mi, S. et al. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nature Med. 13, 1228\u20131233 (2007)","journal-title":"Nature Med."},{"key":"BFnature12647_CR43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1254\/jphs.FM0070073","volume":"106","author":"K Kawashima","year":"2008","unstructured":"Kawashima, K. & Fujii, T. Basic and clinical aspects of non-neuronal acetylcholine: overview of non-neuronal cholinergic systems and their biological significance. J. Pharmacol. Sci. 106, 167\u2013173 (2008)","journal-title":"J. Pharmacol. Sci."},{"key":"BFnature12647_CR44","doi-asserted-by":"crossref","first-page":"17280","DOI":"10.1073\/pnas.1010263107","volume":"107","author":"JN Stern","year":"2010","unstructured":"Stern, J. N. et al. Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells. Proc. Natl Acad. Sci. USA 107, 17280\u201317285 (2010)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature12647_CR45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neures.2011.10.002","volume":"72","author":"AJ Steelman","year":"2012","unstructured":"Steelman, A. J., Thompson, J. P. & Li, J. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication. Neurosci. Res. 72, 32\u201342 (2012)","journal-title":"Neurosci. Res."},{"key":"BFnature12647_CR46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","volume":"11","author":"GK Matsushima","year":"2001","unstructured":"Matsushima, G. K. & Morell, P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11, 107\u2013116 (2001)","journal-title":"Brain Pathol."},{"key":"BFnature12647_CR47","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa052643","volume":"355","author":"L Kappos","year":"2006","unstructured":"Kappos, L. et al. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N. Engl. J. Med. 355, 1124\u20131140 (2006)","journal-title":"N. Engl. J. Med."},{"key":"BFnature12647_CR48","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(02)08430-1","volume":"359","author":"L Durelli","year":"2002","unstructured":"Durelli, L. et al. Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN). Lancet 359, 1453\u20131460 (2002)","journal-title":"Lancet"},{"key":"BFnature12647_CR49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-5728(93)90244-S","volume":"46","author":"A Noronha","year":"1993","unstructured":"Noronha, A., Toscas, A. & Jensen, M. A. Interferon \u03b2 decreases T cell activation and interferon \u03b3 production in multiple sclerosis. J. Neuroimmunol. 46, 145\u2013153 (1993)","journal-title":"J. Neuroimmunol."},{"key":"BFnature12647_CR50","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.C200176200","volume":"277","author":"V Brinkmann","year":"2002","unstructured":"Brinkmann, V. et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277, 21453\u201321457 (2002)","journal-title":"J. Biol. Chem."},{"key":"BFnature12647_CR51","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/emboj\/19.9.1998","volume":"19","author":"T Kondo","year":"2000","unstructured":"Kondo, T. & Raff, M. The Id4 HLH protein and the timing of oligodendrocyte differentiation. EMBO J. 19, 1998\u20132007 (2000)","journal-title":"EMBO J."},{"key":"BFnature12647_CR52","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0896-6273(01)00237-9","volume":"29","author":"S Wang","year":"2001","unstructured":"Wang, S., Sdrulla, A., Johnson, J. E., Yokota, Y. & Barres, B. A. A role for the helix-loop-helix protein Id2 in the control of oligodendrocyte development. Neuron 29, 603\u2013614 (2001)","journal-title":"Neuron"},{"key":"BFnature12647_CR53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/brb3.33","volume":"2","author":"Y Pang","year":"2012","unstructured":"Pang, Y. et al. Neuron-oligodendrocyte myelination co-culture derived from embryonic rat spinal cord and cerebral cortex. Brain Behav. 2, 53\u201367 (2012)","journal-title":"Brain Behav."},{"key":"BFnature12647_CR54","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.mcn.2006.11.008","volume":"34","author":"M Izrael","year":"2007","unstructured":"Izrael, M. et al. Human oligodendrocytes derived from embryonic stem cells: Effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. Mol. Cell. Neurosci. 34, 310\u2013323 (2007)","journal-title":"Mol. Cell. Neurosci."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature12647.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature12647","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature12647.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T09:59:54Z","timestamp":1716026394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature12647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,9]]},"references-count":54,"journal-issue":{"issue":"7471","published-print":{"date-parts":[[2013,10,17]]}},"alternative-id":["BFnature12647"],"URL":"https:\/\/doi.org\/10.1038\/nature12647","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718138087.793485329","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718138087.793485412","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718138087.793488216","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718138087.793485842","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,9]]},"assertion":[{"value":"4 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}